Efficacy and Safety of Switching from Adalimumab to Baricitinib: Phase 3 Data in Patients with Rheumatoid ArthritisPeter C. Taylor,Edward Keystone,Robert Ortmann,Maher Issa,Li Xie,David Muram,John Bradley,Stephanie de Bono,Terence Rooney,Yoshiya Tanaka,Rafat FaraawiARTHRITIS & RHEUMATOLOGY(2017)引用 23|浏览26暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要